| scholarly article | Q13442814 |
| P50 | author | Ricky N. Bluthenthal | Q46579977 |
| Thomas J Stopka | Q64481657 | ||
| Patricia B Pavlinac | Q95980600 | ||
| P2093 | author name string | Richard S Garfein | |
| Elise D Riley | |||
| Alessandra Ross | |||
| B Karen Haye | |||
| P2860 | cites work | Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey. | Q25255650 |
| Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence | Q28249288 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection | Q33650138 | ||
| Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007. | Q33977230 | ||
| Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. | Q33977256 | ||
| The role of needle exchange programs in HIV prevention. | Q34196402 | ||
| Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel | Q36144756 | ||
| New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access | Q36274926 | ||
| Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. | Q36575203 | ||
| Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal | Q36579567 | ||
| HIV prevention for injecting drug users: the first 25 years and counting | Q37180030 | ||
| Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program | Q38473166 | ||
| Lower syringe sharing and re-use after syringe legalization in Rhode Island | Q42615685 | ||
| Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco | Q43657708 | ||
| Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. | Q44457466 | ||
| Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. | Q46215792 | ||
| Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia. | Q46322577 | ||
| Epidemiology of hepatitis C in the United States. | Q50656203 | ||
| Legal needle buying in St. Louis | Q52861375 | ||
| Approval of syringe exchange programs in California: results from a local approach to HIV prevention | Q56504559 | ||
| Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City | Q58404493 | ||
| The estimated prevalence and incidence of HIV in 96 large US metropolitan areas | Q64134569 | ||
| Sharing of drug preparation equipment as a risk factor for hepatitis C | Q73466639 | ||
| Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence | Q73854906 | ||
| P433 | issue | 4 | |
| P921 | main subject | pharmacy | Q614304 |
| California | Q99 | ||
| P304 | page(s) | 576-585 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Journal of Urban Health | Q15760615 |
| P1476 | title | Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now? | |
| P478 | volume | 87 |
| Q33977256 | Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. |
| Q36064140 | Demographic, risk, and spatial factors associated with over-the-counter syringe purchase among injection drug users |
| Q34980340 | Drug-related deaths and the sales of needles through pharmacies |
| Q33977300 | Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California |
| Q37368407 | Factors associated with presence of pharmacies and pharmacies that sell syringes over-the-counter in Los Angeles County |
| Q40339556 | Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015. |
| Q34941301 | Nonprescription syringe sales: a missed opportunity for HIV prevention in California |
| Q36910528 | Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010. |
Search more.